Qiagen to acquire U.K. firm that makes genetic tests

09/22/2009 | Forbes

German firm Qiagen said it agreed to acquire DxS, a U.K.-based maker of genetic tests, in an effort to broaden its cancer diagnostics business. The deal entitles DxS to receive $95 million in cash from Qiagen and up to $35 million in additional payments if certain milestones are met.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations